The utility of lumbar spine trabecular bone score and femoral neck bone mineral density for identifying asymptomatic vertebral fractures in well-compensated type 2 diabetic patients
Zhukouskaya, V. V., Ellen-Vainicher, C., Gaudio, A., Privitera, F., Cairoli, E., Ulivieri, F. M., Palmieri, S., Morelli, V., Grancini, V., Orsi, E., Masserini, B., Spada, A. M., Fiore, C. E., Chiodini, I.
Published in Osteoporosis international (01.01.2016)
Published in Osteoporosis international (01.01.2016)
Get full text
Journal Article
Effects of insulin therapy optimization with sensor augmented pumps on glycemic control and body composition in people with cystic fibrosis-related diabetes
Grancini, V., Alicandro, G., Porcaro, L. L., Zazzeron, L., Gramegna, A., Morlacchi, L. C., Rossetti, V., Gaglio, A., Resi, V., Daccò, V., Blasi, F., Orsi, E.
Published in Frontiers in endocrinology (Lausanne) (31.08.2023)
Published in Frontiers in endocrinology (Lausanne) (31.08.2023)
Get full text
Journal Article
Erratum to: The utility of lumbar spine trabecular bone score and femoral neck bone mineral density for identifying asymptomatic vertebral fractures in well-compensated type 2 diabetic patients
Zhukouskaya, V. V., Eller-Vainicher, C., Gaudio, A., Privitera, F., Cairoli, E., Ulivieri, F. M., Palmieri, S., Morelli, V., Grancini, V., Orsi, E., Masserini, B., Spada, A. M., Fiore, C. E., Chiodini, I.
Published in Osteoporosis international (2016)
Published in Osteoporosis international (2016)
Get full text
Journal Article
632 Change in insulin secretion and sensitivity in people with cystic fibrosis and negative history for diabetes after 6 months of elexacaftor/tezacaftor/ivacaftor therapy
Daccò, V., Zazzeron, L., Alicandro, G., Grancini, V., Orsi, E., Cogliati, I.
Published in Journal of cystic fibrosis (01.09.2024)
Published in Journal of cystic fibrosis (01.09.2024)
Get full text
Journal Article
574 Effects on metabolic control and body composition of insulin therapy optimization with sensor-augmented pump in people with cystic fibrosis–related diabetes
Zazzeron, L., Grancini, V., Alicandro, G., Gramegna, A., Morlacchi, L., Bulfamante, A., Daccò, V., Blasi, F.
Published in Journal of cystic fibrosis (01.10.2023)
Published in Journal of cystic fibrosis (01.10.2023)
Get full text
Journal Article
P160 Effects of elexacaftor/tezacaftor/ivacaftor triple combination therapy on glycaemic control and body composition in patients with cystic fibrosis related diabetes
Zazzeron, L., Gramegna, A., Grancini, V., Bulfamante, A.M.C., Piedepalumbo, F., Lanfranchi, C., Dacco, V., Orsi, E., Blasi, F.B.A.
Published in Journal of cystic fibrosis (01.06.2023)
Published in Journal of cystic fibrosis (01.06.2023)
Get full text
Journal Article
SGLT2 inhibitors improve hepatic fibrosis assessed by Fibroscan in NAFLD patients with type 2 diabetes: A five-year follow-up study
Lombardi, R., Cespiati, A., Mantovani, A., Maffi, G., Del Zanna, E., Francione, P., Cinque, F., Villani, R., Maffeis, C., Passigato, N., Orsi, E., Grancini, V., Pisano, G., Airaghi, L., Targher, G., Serviddio, G., Fargion, S., Fracanzani, A.L.
Published in Digestive and liver disease (01.03.2023)
Published in Digestive and liver disease (01.03.2023)
Get full text
Journal Article